Haemonetics | HAE - Selling And Administration Expenses

Stock Price
59.92
Daily Change
0.43 0.72%
Monthly
2.27%
Yearly
-8.55%
Q1 Forecast
58.11

Haemonetics reported $109.15M in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Avanos Medical USD 78.8M 1.2M Dec/2025
Baxter International USD 761M 53M Dec/2025
Becton, Dickinson and Co. USD 1.39B 27M Dec/2025
Boston Scientific USD 1.83B 93M Dec/2025
Cerus USD 19.33M 1.55M Dec/2024
Cooper Companies USD 373.1M 46.1M Dec/2025
Fresenius EUR 819M 143M Dec/2025
Fresenius Medical Care EUR 785M 79.56M Dec/2025
Globus Medical USD 318.48M 4.88M Dec/2025
Haemonetics USD 109.15M 7.54M Dec/2025
Hologic USD 2.5B 2.24B Dec/2025
ICU Medical USD 155.81M 3.04M Dec/2025
Intuitive Surgical USD 687.1M 113.8M Dec/2025
Masimo USD 128M 11.6M Dec/2025
Medtronic 2.97B 159M Sep/2025
Merit Medical Systems USD 114.83M 7.45M Dec/2025
Neogen USD 107.5M 1.56M Sep/2025
OraSure Technologies USD -0.06 0.05 Sep/2024
Quidel USD 194.4M 7.5M Dec/2025
ResMed USD 278.4M 19.2M Dec/2025
STAAR Surgical USD 38.94M 20.44M Dec/2025
Steris USD 352.3M 2.6M Dec/2025
Stryker USD 2.14B 150M Dec/2025
Surmodics USD 14.58M 2.05M Sep/2024
Teleflex USD 222.37M 59.4M Dec/2025
Terumo JPY 105.26B 7.38B Dec/2025
Thermo Fisher Scientific USD 1.98B 182M Dec/2025
US Physical Therapy USD 18.12M 711K Dec/2025
Zimmer Biomet Holdings USD 855.7M 44.3M Dec/2025